JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 19 No. 4 393-396
© 1978 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kung, H. F.
Right arrow Articles by Blau, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kung, H. F.
Right arrow Articles by Blau, M.

Pancreas Specificity of Iodo and Bromo Aliphatic Amino Acid Analogs: Concise Communication

Hank F. Kung, Syed Gilani and Monte Blau

State University of New York at Buffalo and Roswell Park Memorial Institute, Buffalo, New York

Correspondence: For reprints contact: H. F. Kung, Dept. of Nuclear Medicine, SUNY/Buffalo, VA Hospital, 3495 Bailey Ave., Buffalo, NY 14215.

ABSTRACT

Isosteric replacement of a methyl group by a halogen atom (bromine or iodine) in natural compounds often does not impair chemical or biologic properties. Iodo and bromo aliphatic amino acid analogs have been synthesized and studied for possible use as pancreas imaging agents.

Rather than using the short-lived gamma-emitting isotopes of bromine suitable for scanning, we prepared the C-14-labeled compounds. The valine analog, ß-bromo-{alpha}-aminobutyric acid, was synthesized from [14C] L-threonine, and its distribution was studied in rats. Contrary to expectations, this compound showed neither pancreatic uptake nor any other amino acid behavior. The failure of this bromo-for-methyl substituted compound to be biologically active is rather surprising, in view of the good match in physical properties and previous success in analog localization.

Iodo analogs of leucine ({gamma}-iodo-{alpha}-aminopentanoic acid) and valine (ß-iodo-{alpha}-aminobutyric acid) have been prepared with I-125 labels. These compounds proved to be quite unstable and were rapidly deiodinated.

It is clear that these bromo and iodo analogs of aliphatic amino acids are not useful as pancreas-localizing agents.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1978 by the Society of Nuclear Medicine.